miRNAs as attractive diagnostic and therapeutic targets for Familial Mediterranean Fever

Hamza Malik Okuyan1,2, Mehmet A Begen3

  • 1Department of Physiology and Pharmacology, Schulich School of Medicine and Dentistry, University of Western Ontario, London, Canada.

Modern Rheumatology
|January 11, 2021
PubMed

Insights

Familial Mediterranean Fever (FMF) involves genetic and epigenetic factors like microRNAs (miRNAs). These miRNAs may play a role in FMF pathogenesis and offer future diagnostic and therapeutic potential.

Area of Science:

  • Genetics and Molecular Biology
  • Immunology
  • RNA Biology

Background:

  • Familial Mediterranean Fever (FMF) is an inherited autoinflammatory disorder characterized by recurrent fever, inflammation, and serositis.
  • While genetics are primary, epigenetic factors, including microRNAs (miRNAs), are increasingly recognized for their role in FMF pathogenesis.
  • MicroRNAs are small noncoding RNAs that regulate gene expression and are implicated in cellular processes relevant to FMF, such as inflammation, apoptosis, and autophagy.

Purpose of the Study:

  • To review recent advances in understanding the clinical significance and mechanisms of microRNAs in Familial Mediterranean Fever.
  • To explore the potential diagnostic and therapeutic applications of miRNAs in FMF management.

Main Methods:

  • Literature review of recent studies on microRNAs and FMF.
  • Analysis of the role of miRNAs in FMF-associated biological pathways.
  • Discussion of current and future clinical applications of miRNAs in FMF.

Main Results:

  • MicroRNAs are involved in key pathogenic mechanisms of FMF, including inflammation, apoptosis, and autophagy.
  • Specific miRNAs show altered expression in FMF patients, suggesting a role in disease development.
  • MicroRNAs hold promise for FMF diagnosis, monitoring treatment response, and potentially as therapeutic targets.

Conclusions:

  • MicroRNAs are significant contributors to the pathogenesis of Familial Mediterranean Fever.
  • Further research into miRNAs could lead to novel diagnostic biomarkers and therapeutic strategies for FMF.
  • MicroRNAs represent a promising area for advancing FMF patient care.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
23.2K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.4K
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
72